METABOLIC ASSOCIATED FATTY LIVER DISEASE
Clinical trials for METABOLIC ASSOCIATED FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new METABOLIC ASSOCIATED FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for METABOLIC ASSOCIATED FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a gut antibiotic shrink fatty liver? small trial aims to find out
Disease control Recruiting nowThis early-stage trial is testing whether the antibiotic rifaximin can reduce liver fat in people with metabolic fatty liver disease. About 40 adults will take rifaximin pills three times daily for up to 48 weeks, while maintaining diet and exercise. The main goal is to see if li…
Matched conditions: METABOLIC ASSOCIATED FATTY LIVER DISEASE
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New study probes why diabetes patients develop fatty liver
Knowledge-focused Recruiting nowThis study looks at how the hormone glucagon works in people with type 2 diabetes, with or without fatty liver disease. Researchers will give participants low and high doses of glucagon and use scans and blood tests to measure how the liver and heart respond. The goal is to under…
Matched conditions: METABOLIC ASSOCIATED FATTY LIVER DISEASE
Phase: NA • Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
New MRI tech could end painful liver biopsies for fatty liver patients
Knowledge-focused Recruiting nowThis study is testing a new MRI technology to see if it can accurately assess fatty liver disease without needing a liver biopsy. Researchers will scan 500 patients and compare the MRI results with traditional tests. If it works, it could make diagnosis and monitoring much easier…
Matched conditions: METABOLIC ASSOCIATED FATTY LIVER DISEASE
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:46 UTC